FIELD: medicine.
SUBSTANCE: invention relates to chemical-pharmaceutical industry and medicine, namely to pharmaceutical solution of meloxicam for parenteral introduction in therapeutically effective quantity for treatment of rheumatoid arthritis, osteoarthritis, arthrosis, inflammatory and degenerative diseases of joints, which are accompanied with pain syndrome, which contains meloxicam and pharmaceutically acceptable excipients and auxiliary substances, which differs by the fact that it additionally contains glycine, with quantitative ratio of meloxicam and glycine 0.05-0.2 wt %: 0.05-0.1 wt % respectively.
EFFECT: high efficiency with higher safety with respect to development of gastro-intestinal side effects, high stability during storage.
11 cl, 1 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| NON-STEROID ANTI-INFLAMMATORY DRUG | 2007 |
|
RU2464984C2 |
| NONSTEROID ANTIINFLAMMATORY MEDICINAL AGENT | 2007 |
|
RU2345775C1 |
| PHARMACEUTICAL COMPOSITION FOR INFLAMMATION AND PAIN AND ITS PREPARATION METHOD (VERSIONS) | 2012 |
|
RU2604149C2 |
| PHARMACEUTIC COMPOSITION ALPHA-LIPOIC (THIOCTIC) ACID IN FORM OF SOLUTION FOR INFUSIONS AND TREATMENT METHOD | 2009 |
|
RU2419416C1 |
| TOPICAL AGENT FOR TREATING JOINT AND SOFT-TISSUE DISORDERS | 2013 |
|
RU2574008C2 |
| THERAPEUTICAL AGENT POSSESSING ANTIINFLAMMATORY, ANALGETIC, AND ANTIPYRETIC PROPERTIES AND A METHOD FOR PREPARATION THEREOF | 2006 |
|
RU2311179C1 |
| STABLE ANTI-INFLAMMATORY SOLUTIONS FOR INJECTION | 2012 |
|
RU2635521C2 |
| PREPARATION FOR PREVENTING AND TREATING INFLAMMATORY PROCESSES IN ANIMALS | 2019 |
|
RU2725773C1 |
| PHARMACEUTICAL COMPOSITION CONTAINING CHONDROITIN SULPHATE AND/OR HYALURONIDASE AND LIPOSOME FOR LOCAL APPLICATION | 2010 |
|
RU2473350C2 |
| OSTEOARTHRITIS TREATMENT COMPOSITION COMPRISING HYDROPHILISED SULPHASALASINE AND HYALURONIC ACID, AND A METHOD OF PRODUCING SAID COMPOSITION | 2016 |
|
RU2712168C1 |
